Vaccinia Virus induces programmed necrosis in ovarian cancer cells

Molecular Therapy

Volumn 21, Issue 11, 2013, Pages 2074-2086

  Whilding, Lynsey M ^a   Archibald, Kyra M ^a   Kulbe, Hagen ^a   Balkwill, Frances R ^a   Öberg, Daniel ^a,c   McNeish, Iain A ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 8; HIGH MOBILITY GROUP B1 PROTEIN; PHOSPHATIDYLSERINE; RECEPTOR INTERACTING PROTEIN 1; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CELL DEATH; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IN VIVO STUDY; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; ONCOLYTIC VIROTHERAPY; OVARY CANCER; PHARMACOLOGICAL BLOCKING; PROTEIN SECRETION; TRANSMISSION ELECTRON MICROSCOPY; VACCINIA; VACCINIA VIRUS; VIRUS REPLICATION; WILD TYPE;

VACCINIA VIRUS;

ANIMALS; APOPTOSIS; CASPASE 8; CELL LINE, TUMOR; FEMALE; HUMANS; IMIDAZOLES; INDOLES; MICE; MICE, NUDE; MICROSCOPY, ELECTRON, TRANSMISSION; NECROSIS; NEOPLASMS, EXPERIMENTAL; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; OVARIAN NEOPLASMS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTORS; VACCINIA VIRUS;

EID: 84887431193     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.195     Document Type: Article

References (50)

1. Vanderplasschen, A, Hollinshead, M and Smith, GL (1997). Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation. J Gen Virol 78 (Pt 8): 2041-2048.
2. Vanderplasschen, A, Mathew, E, Hollinshead, M, Sim, RB and Smith, GL (1998). Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc Natl Acad Sci USA 95: 7544-7549.
3. Park, BH, Hwang, T, Liu, TC, Sze, DY, Kim, JS, Kwon, HC et al. (2008). Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial. Lancet Oncol 9: 533-542.
4. Breitbach, CJ, Burke, J, Jonker, D, Stephenson, J, Haas, AR, Chow, LQ et al. (2011). Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans. Nature 477: 99-102.
5. Heo, J, Reid, T, Ruo, L, Breitbach, CJ, Rose, S, Bloomston, M et al. (2013). Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer. Nat Med 19: 329-336.
6. Greiner, S, Humrich, JY, Thuman, P, Sauter, B, Schuler, G and Jenne, L (2006). The highly attenuated vaccinia virus strain modified virus Ankara induces apoptosis in melanoma cells and allows bystander dendritic cells to generate a potent anti-tumoral immunity. Clin Exp Immunol 146: 344-353.
7. Humlová, Z, Vokurka, M, Esteban, M and Melková, Z (2002). Vaccinia virus induces apoptosis of infected macrophages. J Gen Virol 83(Pt 11): 2821-2832.
8. Moloughney, JG, Monken, CE, Tao, H, Zhang, H, Thomas, JD, Lattime, EC et al. (2011). Vaccinia virus leads to ATG12-ATG3 conjugation and deficiency in autophagosome formation. Autophagy 7: 1434-1447.
9. Cho, YS, Challa, S, Moquin, D, Genga, R, Ray, TD, Guildford, M et al. (2009). Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137: 1112-1123.
10. Li, M and Beg, AA (2000). Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors: novel mechanism for killing virus-infected cells. J Virol 74: 7470-7477.
11. Chan, FK, Shisler, J, Bixby, JG, Felices, M, Zheng, L, Appel, M et al. (2003). A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J Biol Chem 278: 51613-51621.
12. Sun, L, Wang, H, Wang, Z, He, S, Chen, S, Liao, D et al. (2012). Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148: 213-227.
13. Young, AM, Archibald, KM, Tookman, LA, Pool, A, Dudek, K, Jones, C et al. (2012). Failure of translation of human adenovirus mRNA in murine cancer cells can be partially overcome by L4-100K expression in vitro and in vivo. Mol Ther 26: 1676-1688.
14. McNeish, IA, Bell, S, McKay, T, Tenev, T, Marani, M and Lemoine, NR (2003). Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway. Exp Cell Res 286: 186-198.
15. Shen, Y, Li, DD, Wang, LL, Deng, R and Zhu, XF (2008). Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer. Autophagy 4: 1067-1068.
16. Klionsky, DJ, Abdalla, FC, Abeliovich, H, Abraham, RT, Acevedo-Arozena, A, Adeli, K et al. (2012). Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8: 445-544.
17. Leist, M, Single, B, Castoldi, AF, Kuhnle, S and Nicotera, P (1997). Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 185: 1481-1486.
18. Schulze-Osthoff, K, Bakker, AC, Vanhaesebroeck, B, Beyaert, R, Jacob, WA and Fiers, W (1992). Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 267: 5317-5323.
19. Tenev, T, Bianchi, K, Darding, M, Broemer, M, Langlais, C, Wallberg, F et al. (2011). The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 43: 432-448.
20. Feoktistova, M, Geserick, P, Kellert, B, Dimitrova, DP, Langlais, C, Hupe, M et al. (2011). cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 43: 449-463.
21. Thome, M, Schneider, P, Hofmann, K, Fickenscher, H, Meinl, E, Neipel, F et al. (1997). Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386: 517-521.
22. Kettle, S, Alcamí, A, Khanna, A, Ehret, R, Jassoy, C and Smith, GL (1997). Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta- converting enzyme and protects virus-infected cells from TNF-and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever. J Gen Virol 78 (Pt 3): 677-685.
23. Coward, J, Kulbe, H, Chakravarty, P, Leader, D, Vassileva, V, Leinster, DA et al. (2011). Interleukin-6 as a therapeutic target in human ovarian cancer. Clin Cancer Res 17: 6083-6096.
24. Kulbe, H, Chakravarty, P, Leinster, DA, Charles, KA, Kwong, J, Thompson, RG et al.; Australian Ovarian Cancer Study Group. (2012). A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment. Cancer Res 72: 66-75.
25. Salako, MA, Kulbe, H, Ingemarsdotter, CK, Pirlo, KJ, Williams, SL, Lockley, M et al. (2011). Inhibition of the inflammatory cytokine TNF-a increases adenovirus activity in ovarian cancer via modulation of cIAP1/2 expression. Mol Ther 19: 490-499.
26. Degterev, A, Hitomi, J, Germscheid, M, Ch'en, IL, Korkina, O, Teng, X et al. (2008). Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4: 313-321.
27. Zhao, J, Jitkaew, S, Cai, Z, Choksi, S, Li, Q, Luo, J et al. (2012). Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNFinduced necrosis. Proc Natl Acad Sci USA 109: 5322-5327.
28. Zhai, D, Yu, E, Jin, C, Welsh, K, Shiau, CW, Chen, L et al. (2010). Vaccinia virus protein F1L is a caspase-9 inhibitor. J Biol Chem 285: 5569-5580.
29. Wasilenko, ST, Banadyga, L, Bond, D and Barry, M (2005). The vaccinia virus F1L protein interacts with the proapoptotic protein Bak and inhibits Bak activation. J Virol 79: 14031-14043.
30. Guo, ZS, Naik, A, O'Malley, ME, Popovic, P, Demarco, R, Hu, Y et al. (2005). The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2. Cancer Res 65: 9991-9998.
31. Liskova, J, Knitlova, J, Honner, R and Melkova, Z (2011). Apoptosis and necrosis in vaccinia virus-infected HeLa G and BSC-40 cells. Virus Res 160: 40-50.
32. Sawai, H and Domae, N (2011). Discrimination between primary necrosis and apoptosis by necrostatin-1 in Annexin V-positive/propidium iodide-negative cells. Biochem Biophys Res Commun 411: 569-573.
33. Daugas, E, Susin, SA, Zamzami, N, Ferri, KF, Irinopoulou, T, Larochette, N et al. (2000). Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 14: 729-739.
34. Boujrad, H, Gubkina, O, Robert, N, Krantic, S and Susin, SA (2007). AIF-mediated programmed necrosis: a highly regulated way to die. Cell Cycle 6: 2612-2619.
35. Cabon, L, Galán-Malo, P, Bouharrour, A, Delavallée, L, Brunelle-Navas, MN, Lorenzo, HK et al. (2012). BID regulates AIF-mediated caspase-independent necroptosis by promoting BAX activation. Cell Death Differ 19: 245-256.
36. Kroemer, G, Galluzzi, L, Vandenabeele, P, Abrams, J, Alnemri, ES, Baehrecke, EH et al. (2009) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16: 3-11.
37. Galluzzi, L, Kepp, O, Morselli, E, Vitale, I, Senovilla, L, Pinti, M et al. (2010). Viral strategies for the evasion of immunogenic cell death. J Intern Med 267: 526-542.
38. Kettle, S, Blake, NW, Law, KM and Smith, GL (1995). Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M® 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model. Virology 206: 136-147.
39. Zhang, H, Monken, CE, Zhang, Y, Lenard, J, Mizushima, N, Lattime, EC et al. (2006). Cellular autophagy machinery is not required for vaccinia virus replication and maturation. Autophagy 2: 91-95.
40. Kulbe, H, Thompson, R, Wilson, JL, Robinson, S, Hagemann, T, Fatah, R et al. (2007). The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumorpromoting network in epithelial ovarian cancer cells. Cancer Res 67: 585-592.
41. Challa, S, Woelfel, M, Guildford, M, Moquin, D and Chan, FK (2010). Viral cell death inhibitor MC159 enhances innate immunity against vaccinia virus infection. J Virol 84: 10467-10476.
42. Mack, C, Sickmann, A, Lembo, D and Brune, W (2008). Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein. Proc Natl Acad Sci USA 105: 3094-3099.
43. Upton, JW, Kaiser, WJ and Mocarski, ES (2010). Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7: 302-313.
44. Li, NF, Broad, S, Lu, YJ, Yang, JS, Watson, R, Hagemann, T et al. (2007). Human ovarian surface epithelial cells immortalized with hTERT maintain functional pRb and p53 expression. Cell Prolif 40: 780-794.
45. Li, NF, Wilbanks, G, Balkwill, F, Jacobs, IJ, Dafou, D and Gayther, SA (2004). A modified medium that significantly improves the growth of human normal ovarian surface epithelial (OSE) cells in vitro. Lab Invest 84: 923-931.
46. Roby, KF, Taylor, CC, Sweetwood, JP, Cheng, Y, Pace, JL, Tawfik, O et al. (2000). Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis 21: 585-591.
47. Connolly, DC, Bao, R, Nikitin, AY, Stephens, KC, Poole, TW, Hua, X et al. (2003). Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res 63: 1389-1397.
48. Hunt, JM and Marcus, PI (1974). Mechanism of Sindbis virus-induced intrinsic interference with vesicular stomatitis virus replication. J Virol 14: 99-109.
49. Bampton, ET, Goemans, CG, Niranjan, D, Mizushima, N and Tolkovsky, AM (2005). The dynamics of autophagy visualized in live cells: from autophagosome formation to fusion with endo/lysosomes. Autophagy 1: 23-36.
50. Workman, P, Aboagye, EO, Balkwill, F, Balmain, A, Bruder, G, Chaplin, DJ et al.; Committee of the National Cancer Research Institute. (2010). Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102: 1555-1577.